Results 61 to 70 of about 17,241 (223)

Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage [PDF]

open access: yes, 2016
Background: A global programme to eliminate lymphatic filariasis (GPELF) is underway, yet two key programmatic features are currently still lacking: (1) the extension of efforts to all lymphatic filariasis (LF) endemic countries, and (2) the expansion of
Steinmann, P.   +17 more
core   +1 more source

Preparation of Ecofriendly Formulations Containing Biologically Active Monoterpenes with Their Fumigant and Residual Toxicities against Adults of Culex pipiens

open access: yesJournal of Tropical Medicine, Volume 2016, Issue 1, 2016., 2016
Different mixtures of monoterpenes (ketone, alcohol, and alkene) were loaded on paper discs and wax and their knockdown activities were evaluated against Culex pipiens adults. Some individual monoterpenes were also evaluated by residual toxicity technique.
Mohamed E. I. Badawy   +5 more
wiley   +1 more source

The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia?

open access: yesTropical Medicine and Infectious Disease, 2018
Lymphatic filariasis (LF) infects an estimated 120 million people worldwide, with a further 856 million considered at risk of infection and requiring preventative chemotherapy.
C. Gordon, Malcolm K. Jones, D. McManus
semanticscholar   +1 more source

Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea [PDF]

open access: yes, 2015
The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 with the goal of interrupting transmission of lymphatic filariasis (LF) through multiple rounds of mass drug administration (MDA).
Bockarie, Moses J.   +25 more
core   +1 more source

Bancroftian Filariasis: Chyluria/Hematuria (Report of 42 cases)

open access: yesJournal of Nepal Medical Association, 2003
NA
Santosh M Shrestha, Sobhana Shrestha
doaj   +1 more source

Evaluation of larvicidal activity of Senecio laetus Edgew. against the malarial vector, Anopheles stephensi , dengue vector, Aedes aegypti and Bancroftian filariasis vector, Culex quinquefasciatus

open access: yes, 2018
The vector-borne diseases caused by mosquitoes are one of the major health problems around the world especially in tropical and sub-tropical countries. The present study was carried out to evaluate the larvicidal potential of petroleum ether, chloroform,
Sofi Imtiyaz Ali   +2 more
semanticscholar   +1 more source

Lymphatic Filariasis

open access: yesSpringer Singapore, 2020
Wuchereria bancrofti, Brugia malayi, and B. timori are mosquito-borne lymphatic-dwelling nematode parasites that are important causes of morbidity, disability, and social stigma in tropical and subtropical countries. The total population at risk is now
R. Knight
semanticscholar   +1 more source

Insecticide resistance in Culex quinquefasciatus from Zanzibar: implications for vector control programmes. [PDF]

open access: yes, 2012
\ud \ud Zanzibar has a long history of lymphatic filariasis (LF) caused by the filarial parasite Wuchereria bancrofti, and transmitted by the mosquito Culex quinquefasciatus Say.
Ali, Abdullah S.   +31 more
core   +1 more source

Spatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New Guinea. [PDF]

open access: yes, 2003
The spatial variation of Wuchereria bancrofti and Plasmodium falciparum infection densities was measured in a rural area of Papua New Guinea where they share anopheline vectors. The spatial correlation of W.
James W Kazura   +17 more
core   +1 more source

Cofactor Independent Phosphoglycerate Mutase of Brugia malayi Induces a Mixed Th1/Th2 Type Immune Response and Inhibits Larval Development in the Host

open access: yesBioMed Research International, Volume 2014, Issue 1, 2014., 2014
Lymphatic filariasis is a major debilitating disease, endemic in 72 countries putting more than 1.39 billion people at risk and 120 million are already infected. Despite the significant progress in chemotherapeutic advancements, there is still need for other measures like development of an effective vaccine or discovery of novel drug targets.
Prashant K. Singh   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy